Literature DB >> 27500468

Melatonin as an antioxidant: under promises but over delivers.

Russel J Reiter1, Juan C Mayo2, Dun-Xian Tan2, Rosa M Sainz2, Moises Alatorre-Jimenez2, Lilian Qin2.   

Abstract

Melatonin is uncommonly effective in reducing oxidative stress under a remarkably large number of circumstances. It achieves this action via a variety of means: direct detoxification of reactive oxygen and reactive nitrogen species and indirectly by stimulating antioxidant enzymes while suppressing the activity of pro-oxidant enzymes. In addition to these well-described actions, melatonin also reportedly chelates transition metals, which are involved in the Fenton/Haber-Weiss reactions; in doing so, melatonin reduces the formation of the devastatingly toxic hydroxyl radical resulting in the reduction of oxidative stress. Melatonin's ubiquitous but unequal intracellular distribution, including its high concentrations in mitochondria, likely aid in its capacity to resist oxidative stress and cellular apoptosis. There is credible evidence to suggest that melatonin should be classified as a mitochondria-targeted antioxidant. Melatonin's capacity to prevent oxidative damage and the associated physiological debilitation is well documented in numerous experimental ischemia/reperfusion (hypoxia/reoxygenation) studies especially in the brain (stroke) and in the heart (heart attack). Melatonin, via its antiradical mechanisms, also reduces the toxicity of noxious prescription drugs and of methamphetamine, a drug of abuse. Experimental findings also indicate that melatonin renders treatment-resistant cancers sensitive to various therapeutic agents and may be useful, due to its multiple antioxidant actions, in especially delaying and perhaps treating a variety of age-related diseases and dehumanizing conditions. Melatonin has been effectively used to combat oxidative stress, inflammation and cellular apoptosis and to restore tissue function in a number of human trials; its efficacy supports its more extensive use in a wider variety of human studies. The uncommonly high-safety profile of melatonin also bolsters this conclusion. It is the current feeling of the authors that, in view of the widely diverse beneficial functions that have been reported for melatonin, these may be merely epiphenomena of the more fundamental, yet-to-be identified basic action(s) of this ancient molecule.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diseases of aging; drug toxicity; free radicals; ischemia/reperfusion; mitochondria-targeted antioxidant; organ transplantation; statins

Mesh:

Substances:

Year:  2016        PMID: 27500468     DOI: 10.1111/jpi.12360

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  319 in total

1.  Melatonin Represses Oil and Anthocyanin Accumulation in Seeds.

Authors:  Dong Li; Yuan Guo; Da Zhang; Shuangcheng He; Jingyun Gong; Haoli Ma; Xin Gao; Zhonghua Wang; Lixi Jiang; Xiaoling Dun; Shengwu Hu; Mingxun Chen
Journal:  Plant Physiol       Date:  2020-04-30       Impact factor: 8.340

2.  Melatonin Prevents the Harmful Effects of Obesity on the Brain, Including at the Behavioral Level.

Authors:  Adrian Rubio-González; Juan Carlos Bermejo-Millo; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; José Antonio Boga; Ignacio Vega-Naredo; Beatriz Caballero; Juan José Solano; Ana Coto-Montes
Journal:  Mol Neurobiol       Date:  2017-10-30       Impact factor: 5.590

3.  Melatonin and its derivatives counteract the ultraviolet B radiation-induced damage in human and porcine skin ex vivo.

Authors:  Cezary Skobowiat; Anna A Brożyna; Zorica Janjetovic; Saowanee Jeayeng; Allen S W Oak; Tae-Kang Kim; Uraiwan Panich; Russel J Reiter; Andrzej T Slominski
Journal:  J Pineal Res       Date:  2018-05-21       Impact factor: 13.007

4.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

Review 5.  Utilizing melatonin to combat bacterial infections and septic injury.

Authors:  Wei Hu; Chao Deng; Zhiqiang Ma; Dongjin Wang; Chongxi Fan; Tian Li; Shouyin Di; Bing Gong; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

6.  Evaluation of melatonin and AFMK levels in women with breast cancer.

Authors:  Tialfi Bergamin de Castro; Newton Antônio Bordin-Junior; Eduardo Alves de Almeida; Debora Aparecida Pires de Campos Zuccari
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633

7.  Poor Quality Control of Over-the-Counter Melatonin: What They Say Is Often Not What You Get.

Authors:  Madeleine M Grigg-Damberger; Dessislava Ianakieva
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

8.  Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca2+]c/VDAC-[Ca2+]m axis by activation of MAPK/ERK signaling pathway.

Authors:  Hang Zhu; Qinhua Jin; Yang Li; Qiang Ma; Jing Wang; Dandan Li; Hao Zhou; Yundai Chen
Journal:  Cell Stress Chaperones       Date:  2017-07-01       Impact factor: 3.667

Review 9.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

Review 10.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.